Showing results (1-10 of 535) with videos related to
Sort By:
Pageof 54
European Urology|April 29, 2008
(I) Re: prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/mlMonique RoobolUrology|February 15, 2005
Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/mL or less in a population-based screening setting? (ERSPC, section Rotterdam)Monique J Roobol, Dina W Roobol, Fritz H SchröderCurrent Opinion in Urology|February 9, 2011
Contemporary role of prostate cancer gene 3 in the management of prostate cancerMonique J RoobolExpert Opinion on Medical Diagnostics|July 24, 2013
The prostate-specific antigen testMonique J RoobolThe Urologic Clinics of North America|April 15, 2014
International perspectives on screeningMonique J RoobolTranslational Andrology and Urology|March 30, 2018
Screening for prostate cancer: are organized screening programs necessary?Monique J RoobolWorld Journal of Urology|June 10, 2008
Algorithms, nomograms and the detection of indolent prostate cancerMonique J RoobolEuropean Journal of Biochemistry|October 16, 1978
The role of guanine nucleotides in the interaction between aminoacyl-tRNA and elongation factor 1 of Artemia salinaK Roobol, W MöllerMolecular Biology Reports|August 14, 1981
Protein synthesis in artemia salina. Eucaryotic elongation factor eEF-Ts is a transphosphorylaseK Roobol, W MöllerEuropean Journal of Cell Biology|March 19, 1999
Subunits of the eukaryotic cytosolic chaperonin CCT do not always behave as components of a uniform hetero-oligomeric particleA Roobol, M J CardenPageof 54